Finance

Lists
Q1 2027 earnings • released • EPS miss -12.39% • Revenue beat +7.08%
See results
NEPHROPLUS:NSE
Nephrocare Health Services Ltd
₹700.00
+3.57%
(+24.10) 1D
Aug 14, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NEPHROPLUS...
Open
₹675.90
High
₹722.00
Low
₹675.60
Mkt. cap
70.39B
Avg. vol.
0.00
Volume
261.30K
P/E ratio
86.39
52-wk high
₹769.75
52-wk low
₹446.00
EPS
₹8.10
No. of employees
2K
Open
₹675.90
High
₹722.00
Low
₹675.60
Mkt. cap
70.39B
Avg. vol.
0.00
Volume
261.30K
P/E ratio
86.39
52-wk high
₹769.75
52-wk low
₹446.00
EPS
₹8.10
No. of employees
2K
About Nephrocare Health Services Ltd
CEO-
Employees2.29K
Founded2009
Headquarters-
SectorHealth care provider
Last report
Aug 12, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹3.11 / ₹3.55
-12.39%miss
Revenue / Est. (INR)
2.89B / 2.70B
+7.08%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.37B
2.60B
2.66B
2.89B
Cost of goods sold
1.48B
1.52B
1.85B
1.62B
Cost of revenue
1.48B
1.52B
1.85B
1.62B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.22M
-
251.70M
-
Operating expense
536.82M
684.30M
503.40M
799.44M
Total operating expenses
2.02B
2.21B
2.35B
2.42B
Operating income
349.68M
390.04M
304.70M
468.02M
Other non operating income
-3.46M
33.16M
-119.95M
-
EBT including unusual items
139.46M
363.60M
332.19M
410.30M
EBT excluding unusual items
135.88M
363.60M
266.31M
410.30M
Income tax expense
68.32M
41.20M
28.49M
90.56M
Effective tax rate
48.99%
11.33%
8.58%
22.07%
Other operating expenses
271.69M
465.69M
5.03M
554.04M
Net income
71.14M
322.40M
303.70M
319.74M
Net profit margin
3.00%
12.41%
11.43%
11.06%
Earnings per share
-
-
-
3.11
Interest and investment income
24.24M
-
97.07M
-
Interest expense
-251.32M
-59.60M
-9.04M
-22.06M
Net interest expenses
-227.08M
-59.60M
88.03M
-22.06M
Depreciation and amortization charges
208.90M
218.61M
246.63M
245.40M
EBITDA
521.27M
561.64M
492.71M
656.03M
Gain or loss from assets sale
1.12M
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps